Simplex Trading
HARP

Simplex Trading’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Simplex Trading’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$2K – 10277
2023
Q2 		$2K Buy
+300
New +$2.08K ﹤0.01% 8534
2023
Q1 		– Sell
-1,900
Closed -$13K – 10536
2022
Q4 		$13K Buy
+1,900
New +$16K ﹤0.01% 7332
2022
Q3 		– Sell
-200
Closed -$3K – 11240
2022
Q2 		$3K Sell
200
-470
-70% -$12.2K ﹤0.01% 9245
2022
Q1 		$33K Buy
670
+560
+509% +$29K ﹤0.01% 7680
2021
Q4 		$8K Sell
110
-550
-83% -$37.5K ﹤0.01% 9254
2021
Q3 		$92K Hold
660
– – ﹤0.01% 6744
2021
Q2 		$91K Buy
660
+659
+65,900% +$126K ﹤0.01% 6871
2021
Q1 		$10K Sell
1
-2
-67% -$401 ﹤0.01% 7912
2020
Q4 		$48K Buy
3
+2
+200% +$309 ﹤0.01% 6233
2020
Q3 		$20K Buy
+1
New +$144 ﹤0.01% 6378

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Simplex Trading's HARP Position: Q3 2023 in Review

Simplex Trading sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 374 shares — an estimated $2K sold.

Simplex Trading first reported a position in HARP in Q3 2020 and held it in 8 quarters. The position peaked at $80K in Q4 2020. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

  • Simplex Trading reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Simplex Trading sold 374 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2K.
  • Simplex Trading first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • Simplex Trading's Harpoon Therapeutics, Inc. Common Stock position peaked at $80K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.